Skip Nav Destination
Issues
1 April 2015
-
Cover Image
Cover Image
The immunofluorescence image shows myofibroblast-like tumor endothelial cells that have turned on smooth muscle actin (SMA) after TGFβ stimulation. Colocalization of an endothelial marker CD31 (green) and SMA-positive stress fibers (red) can be seen in the same cells. Thus, endothelial heterogeneity creates a spectrum of fibroblast-like cells with different functions in the tumor microenvironment. For details, see article by Xiao and colleagues on page 1244. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Meeting Report
Priority Reports
Clinical Studies
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients
Abdullah A. Osman; David M. Neskey; Panagiotis Katsonis; Ameeta A. Patel; Alexandra M. Ward; Teng-Kuei Hsu; Stephanie C. Hicks; Thomas O. McDonald; Thomas J. Ow; Marcus Ortega Alves; Curtis R. Pickering; Heath D. Skinner; Mei Zhao; Eric M. Sturgis; Merrill S. Kies; Adel El-Naggar; Federica Perrone; Lisa Licitra; Paolo Bossi; Marek Kimmel; Mitchell J. Frederick; Olivier Lichtarge; Jeffrey N. Myers
Integrated Systems and Technologies
Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography
Yann Jamin; Jessica K.R. Boult; Jin Li; Sergey Popov; Philippe Garteiser; Jose L. Ulloa; Craig Cummings; Gary Box; Suzanne A. Eccles; Chris Jones; John C. Waterton; Jeffrey C. Bamber; Ralph Sinkus; Simon P. Robinson
Microenvironment and Immunology
Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition
Lin Xiao; Dae Joong Kim; Clayton L. Davis; James V. McCann; James M. Dunleavey; Alissa K. Vanderlinden; Nuo Xu; Samantha G. Pattenden; Stephen V. Frye; Xia Xu; Mark Onaitis; Elizabeth Monaghan-Benson; Keith Burridge; Andrew C. Dudley
Author Choice
Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer
Carla S. Milagre; Ganga Gopinathan; Gemma Everitt; Richard G. Thompson; Hagen Kulbe; Haihong Zhong; Robert E. Hollingsworth; Richard Grose; David D.L. Bowtell; Daniel Hochhauser; Frances R. Balkwill
Antitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β
Vanina A. Alamino; Iván D. Mascanfroni; María M. Montesinos; Nicolás Gigena; Ana C. Donadio; Ada G. Blidner; Sonia I. Milotich; Sheue-yann Cheng; Ana M. Masini-Repiso; Gabriel A. Rabinovich; Claudia G. Pellizas
Molecular and Cellular Pathobiology
PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion
Ester Bonastre; Sara Verdura; Ilse Zondervan; Federica Facchinetti; Sylvie Lantuejoul; Maria Dolores Chiara; Juan Pablo Rodrigo; Julian Carretero; Enric Condom; Agustin Vidal; David Sidransky; Alberto Villanueva; Luca Roz; Elisabeth Brambilla; Suvi Savola; Montse Sanchez-Cespedes
Therapeutics, Targets, and Chemical Biology
Author Choice
Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer
Yuxuan Wang; Changzheng Liu; Min Luo; Zhengyi Zhang; Jianan Gong; Jingjing Li; Lei You; Lei Dong; Rui Su; Haishuang Lin; Yanni Ma; Fang Wang; Yi Wang; Jie Chen; Junwu Zhang; Hongyan Jia; Yan Kong; Jia Yu
Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle
Pubudu M. Peiris; Aaron Abramowski; James Mcginnity; Elizabeth Doolittle; Randall Toy; Ramamurthy Gopalakrishnan; Shruti Shah; Lisa Bauer; Ketan B. Ghaghada; Christopher Hoimes; Susann M. Brady-Kalnay; James P. Basilion; Mark A. Griswold; Efstathios Karathanasis
Author Choice
Tumor Radiosensitization by Monomethyl Auristatin E: Mechanism of Action and Targeted Delivery
Lisa Buckel; Elamprakash N. Savariar; Jessica L. Crisp; Karra A. Jones; Angel M. Hicks; Daniel J. Scanderbeg; Quyen T. Nguyen; Jason K. Sicklick; Andrew M. Lowy; Roger Y. Tsien; Sunil J. Advani
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets
Marzia Scortegagna; Eric Lau; Tongwu Zhang; Yongmei Feng; Chris Sereduk; Hongwei Yin; Surya K. De; Katrina Meeth; James T. Platt; Casey G. Langdon; Ruth Halaban; Maurizio Pellecchia; Michael A. Davies; Kevin Brown; David F. Stern; Marcus Bosenberg; Ze'ev A. Ronai
Tumor and Stem Cell Biology
Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells
Monica Cojoc; Claudia Peitzsch; Ina Kurth; Franziska Trautmann; Leoni A. Kunz-Schughart; Gennady D. Telegeev; Eduard A. Stakhovsky; John R. Walker; Karl Simin; Stephen Lyle; Susanne Fuessel; Kati Erdmann; Manfred P. Wirth; Mechthild Krause; Michael Baumann; Anna Dubrovska
Phosphotyrosine Signaling Analysis in Human Tumors Is Confounded by Systemic Ischemia-Driven Artifacts and Intra-Specimen Heterogeneity
Aaron S. Gajadhar; Hannah Johnson; Robbert J.C. Slebos; Kent Shaddox; Kerry Wiles; Mary Kay Washington; Alan J. Herline; Douglas A. Levine; Daniel C. Liebler; Forest M. White; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium; on behalf of the Clinical Proteomic Tumor Analysis Consortium
Author Choice
Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer
David M. Neskey; Abdullah A. Osman; Thomas J. Ow; Panagiotis Katsonis; Thomas McDonald; Stephanie C. Hicks; Teng-Kuei Hsu; Curtis R. Pickering; Alexandra Ward; Ameeta Patel; John S. Yordy; Heath D. Skinner; Uma Giri; Daisuke Sano; Michael D. Story; Beth M. Beadle; Adel K. El-Naggar; Merrill S. Kies; William N. William; Carlos Caulin; Mitchell Frederick; Marek Kimmel; Jeffrey N. Myers; Olivier Lichtarge
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.